Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningioma | 13 | 2024 | 110 | 2.970 |
Why?
|
| Meningeal Neoplasms | 13 | 2024 | 173 | 2.880 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 12 | 2017 | 380 | 1.750 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 4 | 2020 | 173 | 0.800 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2024 | 1119 | 0.730 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 28 | 0.670 |
Why?
|
| src-Family Kinases | 1 | 2018 | 83 | 0.610 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2018 | 163 | 0.590 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 355 | 0.540 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 136 | 0.540 |
Why?
|
| Medulloblastoma | 2 | 2017 | 338 | 0.520 |
Why?
|
| Repressor Proteins | 2 | 2019 | 814 | 0.490 |
Why?
|
| Carcinogenesis | 1 | 2017 | 333 | 0.480 |
Why?
|
| Starvation | 1 | 2013 | 15 | 0.440 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 353 | 0.380 |
Why?
|
| Gene Expression Profiling | 7 | 2024 | 1674 | 0.370 |
Why?
|
| Cerebellum | 2 | 2011 | 412 | 0.350 |
Why?
|
| Metabolic Syndrome | 1 | 2013 | 319 | 0.340 |
Why?
|
| Autophagy | 3 | 2019 | 391 | 0.340 |
Why?
|
| Transcriptome | 5 | 2024 | 906 | 0.340 |
Why?
|
| Xenopus | 2 | 2007 | 107 | 0.330 |
Why?
|
| Neurons | 5 | 2011 | 1922 | 0.320 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2011 | 1006 | 0.310 |
Why?
|
| Energy Metabolism | 3 | 2019 | 742 | 0.290 |
Why?
|
| Cell Cycle | 3 | 2019 | 619 | 0.290 |
Why?
|
| Hair Cells, Auditory | 2 | 2017 | 64 | 0.260 |
Why?
|
| Organogenesis | 1 | 2006 | 78 | 0.250 |
Why?
|
| Central Nervous System | 2 | 2007 | 255 | 0.250 |
Why?
|
| Cell Lineage | 2 | 2020 | 348 | 0.240 |
Why?
|
| Sequence Analysis, RNA | 2 | 2024 | 371 | 0.240 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 260 | 0.240 |
Why?
|
| DNA Methylation | 3 | 2024 | 991 | 0.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2024 | 864 | 0.220 |
Why?
|
| Mice | 15 | 2019 | 17637 | 0.210 |
Why?
|
| Animals | 21 | 2024 | 33891 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 469 | 0.210 |
Why?
|
| Obesity | 1 | 2013 | 1949 | 0.200 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 2442 | 0.200 |
Why?
|
| DNA Copy Number Variations | 3 | 2024 | 943 | 0.200 |
Why?
|
| Rhombencephalon | 2 | 2012 | 45 | 0.180 |
Why?
|
| Algorithms | 2 | 2024 | 1577 | 0.180 |
Why?
|
| Liver | 2 | 2020 | 1857 | 0.170 |
Why?
|
| Optic Nerve Glioma | 1 | 2019 | 21 | 0.160 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2019 | 19 | 0.160 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 194 | 0.160 |
Why?
|
| Circadian Clocks | 1 | 2019 | 60 | 0.160 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 3301 | 0.150 |
Why?
|
| Spinal Cord | 2 | 2011 | 302 | 0.150 |
Why?
|
| Cell Differentiation | 4 | 2020 | 1934 | 0.150 |
Why?
|
| Regeneration | 1 | 2020 | 202 | 0.150 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2017 | 16 | 0.140 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2017 | 17 | 0.140 |
Why?
|
| Third Ventricle | 1 | 2017 | 28 | 0.140 |
Why?
|
| Hemangioma, Cavernous | 1 | 2017 | 19 | 0.140 |
Why?
|
| Humans | 21 | 2024 | 122409 | 0.140 |
Why?
|
| Caenorhabditis elegans | 2 | 2013 | 223 | 0.140 |
Why?
|
| Transcription Factors | 5 | 2019 | 2590 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4383 | 0.140 |
Why?
|
| Biomarkers, Tumor | 2 | 2024 | 1431 | 0.140 |
Why?
|
| RNA Interference | 2 | 2017 | 497 | 0.140 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2016 | 16 | 0.140 |
Why?
|
| Prognosis | 3 | 2022 | 4492 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2017 | 1615 | 0.140 |
Why?
|
| Binding Sites | 3 | 2019 | 1298 | 0.130 |
Why?
|
| Neurogenesis | 2 | 2016 | 196 | 0.130 |
Why?
|
| Hearing Loss | 1 | 2017 | 132 | 0.130 |
Why?
|
| alpha-Synuclein | 1 | 2016 | 109 | 0.130 |
Why?
|
| Signal Transduction | 4 | 2018 | 4514 | 0.130 |
Why?
|
| Protein Binding | 3 | 2020 | 1740 | 0.120 |
Why?
|
| Hydrocephalus | 1 | 2017 | 236 | 0.120 |
Why?
|
| tau Proteins | 1 | 2016 | 189 | 0.120 |
Why?
|
| Movement Disorders | 1 | 2017 | 221 | 0.120 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2017 | 306 | 0.120 |
Why?
|
| Male | 13 | 2024 | 59575 | 0.120 |
Why?
|
| Cell Line | 1 | 2019 | 2787 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 5 | 2016 | 1114 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2016 | 678 | 0.110 |
Why?
|
| Cell Movement | 3 | 2012 | 839 | 0.110 |
Why?
|
| Amino Acid Sequence | 4 | 2017 | 2698 | 0.110 |
Why?
|
| Disease Progression | 1 | 2019 | 1994 | 0.110 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 40 | 0.110 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 69 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2013 | 54 | 0.110 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2012 | 17 | 0.100 |
Why?
|
| Respiratory Center | 1 | 2012 | 10 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 1222 | 0.100 |
Why?
|
| Alleles | 1 | 2017 | 1594 | 0.100 |
Why?
|
| Mutation | 3 | 2023 | 5786 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 4310 | 0.100 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 29 | 0.100 |
Why?
|
| Microvilli | 1 | 2011 | 73 | 0.100 |
Why?
|
| In Situ Hybridization | 3 | 2008 | 474 | 0.100 |
Why?
|
| Aged | 4 | 2024 | 18777 | 0.100 |
Why?
|
| HeLa Cells | 1 | 2013 | 808 | 0.090 |
Why?
|
| Lysosomes | 1 | 2013 | 232 | 0.090 |
Why?
|
| Middle Aged | 5 | 2024 | 25586 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2017 | 994 | 0.090 |
Why?
|
| Weight Gain | 1 | 2013 | 377 | 0.090 |
Why?
|
| Aging | 1 | 2017 | 1163 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2016 | 3887 | 0.090 |
Why?
|
| Stem Cells | 2 | 2020 | 710 | 0.090 |
Why?
|
| Female | 11 | 2024 | 64937 | 0.090 |
Why?
|
| Adult | 5 | 2024 | 28743 | 0.080 |
Why?
|
| Periodicity | 1 | 2009 | 56 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 75 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2013 | 805 | 0.080 |
Why?
|
| Embryo, Nonmammalian | 2 | 2007 | 141 | 0.080 |
Why?
|
| Homeostasis | 1 | 2013 | 680 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 2541 | 0.080 |
Why?
|
| Hedgehog Proteins | 1 | 2009 | 192 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6302 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2007 | 658 | 0.080 |
Why?
|
| Models, Biological | 2 | 2020 | 1439 | 0.080 |
Why?
|
| Base Sequence | 2 | 2011 | 3119 | 0.080 |
Why?
|
| Morphogenesis | 1 | 2008 | 213 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 1704 | 0.070 |
Why?
|
| Interneurons | 1 | 2008 | 138 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2017 | 3780 | 0.070 |
Why?
|
| Xenopus Proteins | 1 | 2007 | 60 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3073 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 1889 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 773 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 1 | 2009 | 283 | 0.070 |
Why?
|
| Nervous System | 1 | 2007 | 129 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2020 | 872 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2019 | 746 | 0.060 |
Why?
|
| Young Adult | 1 | 2019 | 8805 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 317 | 0.060 |
Why?
|
| Gene Library | 1 | 2006 | 220 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2006 | 465 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2007 | 401 | 0.060 |
Why?
|
| Gene Knock-In Techniques | 2 | 2017 | 123 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2020 | 701 | 0.050 |
Why?
|
| Xenobiotics | 1 | 2023 | 27 | 0.050 |
Why?
|
| Neurofibromin 2 | 1 | 2023 | 6 | 0.050 |
Why?
|
| Homeodomain Proteins | 3 | 2011 | 547 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 1301 | 0.050 |
Why?
|
| Glucuronosyltransferase | 1 | 2023 | 70 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 240 | 0.050 |
Why?
|
| Dogs | 1 | 2024 | 774 | 0.050 |
Why?
|
| Intermediate Filament Proteins | 1 | 2002 | 27 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2023 | 101 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2019 | 3076 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2002 | 89 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2022 | 116 | 0.050 |
Why?
|
| LIM-Homeodomain Proteins | 2 | 2011 | 40 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 59 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2020 | 64 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 665 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2832 | 0.040 |
Why?
|
| SOX9 Transcription Factor | 1 | 2020 | 83 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2019 | 21 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2011 | 392 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 577 | 0.040 |
Why?
|
| Bile Duct Neoplasms | 1 | 2020 | 112 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2020 | 110 | 0.040 |
Why?
|
| Biomarkers | 2 | 2023 | 2942 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 109 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2315 | 0.040 |
Why?
|
| Retina | 2 | 2016 | 458 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 256 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 858 | 0.040 |
Why?
|
| Smoking | 1 | 2023 | 1026 | 0.040 |
Why?
|
| Protein Phosphatase 2 | 1 | 2017 | 29 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 414 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 267 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 167 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2019 | 212 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2017 | 46 | 0.030 |
Why?
|
| Headache | 1 | 2017 | 107 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 175 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 1355 | 0.030 |
Why?
|
| Imaginal Discs | 1 | 2016 | 11 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 92 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2017 | 331 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 206 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 1475 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 48 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2024 | 15878 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 157 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3306 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2016 | 622 | 0.030 |
Why?
|
| Eye | 1 | 2016 | 227 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 503 | 0.030 |
Why?
|
| Pregnancy | 2 | 2019 | 7101 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 5970 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2017 | 843 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 876 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 1072 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 1 | 2011 | 18 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1023 | 0.020 |
Why?
|
| Electroporation | 1 | 2011 | 33 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 131 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 4984 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4648 | 0.020 |
Why?
|
| Drosophila | 1 | 2016 | 766 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 669 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2793 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 9868 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 331 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 4217 | 0.020 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2009 | 12 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 708 | 0.020 |
Why?
|
| Smoothened Receptor | 1 | 2009 | 28 | 0.020 |
Why?
|
| Hypoventilation | 1 | 2009 | 13 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 2009 | 21 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2011 | 206 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 662 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 755 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 810 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 453 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 110 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2009 | 200 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 560 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 525 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 968 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1000 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1593 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 1007 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2009 | 287 | 0.020 |
Why?
|
| Gastrula | 1 | 2007 | 18 | 0.020 |
Why?
|
| Computational Biology | 1 | 2011 | 793 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2009 | 799 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2007 | 212 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 2779 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 551 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 12036 | 0.010 |
Why?
|
| RNA, Helminth | 1 | 2002 | 8 | 0.010 |
Why?
|
| Genes, Helminth | 1 | 2002 | 21 | 0.010 |
Why?
|
| DNA, Helminth | 1 | 2002 | 22 | 0.010 |
Why?
|
| Multigene Family | 1 | 2002 | 299 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2012 | 8113 | 0.010 |
Why?
|